Company Filing History:
Years Active: 2012-2015
Title: The Innovative Contributions of Andrew Forrest
Introduction
Andrew Forrest is a notable inventor based in Essex, GB. He has made significant strides in the field of pharmaceutical compositions, particularly in the treatment of respiratory diseases. With a total of three patents to his name, Forrest's work is paving the way for advancements in pulmonary administration therapies.
Latest Patents
Forrest's latest patents focus on innovative pharmaceutical compositions designed for pulmonary administration by inhalation. One of his key inventions describes a composition that includes a glitazone, such as pioglitazone or rosiglitazone, combined with one or more pharmaceutically acceptable carriers and/or excipients. This composition is characterized by a glitazone content that consists of at least 95% by weight of the 5R enantiomer and less than 5% by weight of the 5S enantiomer. Additionally, the glitazone is presented in the form of microparticles, enhancing its efficacy in treating respiratory diseases.
Career Highlights
Andrew Forrest is currently associated with Pulmagen Therapeutics Limited, a company focused on inflammation-related therapies. His work at Pulmagen Therapeutics has been instrumental in developing innovative treatments that address critical health issues. Forrest's dedication to research and development has positioned him as a key player in the pharmaceutical industry.
Collaborations
Forrest collaborates with talented individuals such as Harry Finch and Craig Fox. Their combined expertise contributes to the advancement of therapeutic solutions in the field of respiratory health.
Conclusion
Andrew Forrest's contributions to the field of pharmaceutical inventions are noteworthy. His innovative patents and collaborations are set to make a significant impact on the treatment of respiratory diseases. The future looks promising for Forrest and his ongoing work in this vital area of healthcare.